Makindo Medical Notes"One small step for man, one large step for Makindo" |
|
|---|---|
| Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
| MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
Related Subjects: | Dilated Cardiomyopathy | Hypertrophic Cardiomyopathy (HCM - HOCM) | Peripartum Cardiomyopathy | Restrictive Cardiomyopathy | Takotsubo Cardiomyopathy
๐คฐโค๏ธ Peripartum cardiomyopathy (PPCM) is a rare but serious cause of heart failure in late pregnancy or the early postpartum period. Prompt recognition and treatment improve outcomes, but long-term follow-up is essential.
| ๐ซ Peripartum Cardiomyopathy โ Key Points |
|---|
|
A 30-year-old woman, 3 weeks postpartum, presents with progressive breathlessness, orthopnoea, and ankle swelling. She has no prior cardiac history. On exam: raised JVP, basal crackles, and bilateral pitting oedema. Echocardiography shows left ventricular systolic dysfunction with ejection fraction 25%. Management: ๐ Standard heart failure therapy โ diuretics for congestion, ACE inhibitors/ARBs, beta-blockers, and anticoagulation if EF severely reduced. Cardiology follow-up essential. Avoid: โ ACE inhibitors and ARBs during pregnancy (safe postpartum, contraindicated antenatally). Avoid fluid overload with IV fluids.
A 36-year-old woman at 36 weeksโ gestation presents with fatigue, palpitations, and nocturnal breathlessness. Exam reveals tachycardia, displaced apex beat, and basal crepitations. BNP elevated; echo shows dilated LV with EF 30%. Management: ๐ฅ Optimise with pregnancy-safe HF therapies (loop diuretics, beta-blockers such as labetalol, hydralazine + nitrates if afterload reduction needed). Plan delivery in a tertiary centre with cardiology and obstetric input. Avoid: โ ACE inhibitors, ARBs, and mineralocorticoid antagonists in pregnancy (teratogenic). Avoid unnecessary tocolytics that worsen fluid retention.